Tumour biomarkers: homeostasis as a novel prognostic indicator

The term ‘personalized medicine’ refers to a medical procedure that consists in the grouping of patients based on their predicted individual response to therapy or risk of disease. In oncologic patients, a ‘tailored’ therapeutic approach may potentially improve their survival and well-being by not o...

Descripción completa

Detalles Bibliográficos
Autores principales: Falco, Michela, Palma, Giuseppe, Rea, Domenica, De Biase, Davide, Scala, Stefania, D'Aiuto, Massimiliano, Facchini, Gaetano, Perdonà, Sisto, Barbieri, Antonio, Arra, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204124/
https://www.ncbi.nlm.nih.gov/pubmed/27927793
http://dx.doi.org/10.1098/rsob.160254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204124/
https://www.ncbi.nlm.nih.gov/pubmed/27927793
http://dx.doi.org/10.1098/rsob.160254

Ejemplares similares